FUOM
gene geneOn this page
Also known as FLJ26016FucUFucM
Summary
FUOM (fucose mutarotase, HGNC:24733) is a protein-coding gene on chromosome 10q26.3, encoding Fucose mutarotase (A2VDF0). Involved in the interconversion between alpha- and beta-L-fucoses.
Predicted to enable L-fucose mutarotase activity and fucose binding activity. Predicted to be involved in GDP-L-fucose salvage; fucose metabolic process; and fucosylation. Predicted to act upstream of or within female mating behavior and negative regulation of neuron differentiation. Predicted to be active in cytosol.
Source: NCBI Gene 282969 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 33 total
- MANE Select transcript:
NM_001098483
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24733 |
| Approved symbol | FUOM |
| Name | fucose mutarotase |
| Location | 10q26.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ26016, FucU, FucM |
| Ensembl gene | ENSG00000148803 |
| Ensembl biotype | protein_coding |
| OMIM | 617725 |
| Entrez | 282969 |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 11 protein_coding, 2 protein_coding_CDS_not_defined
ENST00000278025, ENST00000368551, ENST00000368552, ENST00000447176, ENST00000465384, ENST00000478895, ENST00000850601, ENST00000863239, ENST00000863240, ENST00000863241, ENST00000863242, ENST00000916332, ENST00000916333
RefSeq mRNA: 4 — MANE Select: NM_001098483
NM_001098483, NM_001301827, NM_001301828, NM_198472
CCDS: CCDS44499, CCDS76364, CCDS7680
Canonical transcript exons
ENST00000278025 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001304268 | 133355158 | 133355436 |
| ENSE00003569089 | 133356640 | 133356738 |
| ENSE00003579291 | 133357187 | 133357255 |
| ENSE00003606447 | 133356943 | 133357013 |
| ENSE00003678039 | 133355738 | 133355811 |
| ENSE00003769574 | 133357923 | 133358019 |
Expression profiles
Bgee: expression breadth ubiquitous, 183 present calls, max score 98.24.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 11.5997 / max 193.6965, expressed in 1703 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 112126 | 9.2425 | 1683 |
| 112123 | 2.0015 | 822 |
| 112125 | 0.2438 | 65 |
| 112124 | 0.1118 | 30 |
Top tissues by expression
247 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right lobe of liver | UBERON:0001114 | 98.24 | gold quality |
| liver | UBERON:0002107 | 95.65 | gold quality |
| ileal mucosa | UBERON:0000331 | 91.13 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 89.57 | gold quality |
| duodenum | UBERON:0002114 | 89.44 | gold quality |
| kidney epithelium | UBERON:0004819 | 88.94 | silver quality |
| adult mammalian kidney | UBERON:0000082 | 88.87 | gold quality |
| small intestine | UBERON:0002108 | 88.87 | gold quality |
| cortex of kidney | UBERON:0001225 | 88.45 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 88.42 | gold quality |
| tibial nerve | UBERON:0001323 | 88.41 | gold quality |
| granulocyte | CL:0000094 | 88.07 | gold quality |
| spleen | UBERON:0002106 | 87.68 | gold quality |
| monocyte | CL:0000576 | 87.47 | gold quality |
| leukocyte | CL:0000738 | 87.25 | gold quality |
| right atrium auricular region | UBERON:0006631 | 86.51 | gold quality |
| metanephros cortex | UBERON:0010533 | 85.60 | gold quality |
| cardiac atrium | UBERON:0002081 | 85.39 | gold quality |
| kidney | UBERON:0002113 | 85.01 | gold quality |
| left coronary artery | UBERON:0001626 | 84.85 | gold quality |
| apex of heart | UBERON:0002098 | 84.85 | gold quality |
| thoracic aorta | UBERON:0001515 | 84.10 | gold quality |
| ascending aorta | UBERON:0001496 | 84.01 | gold quality |
| coronary artery | UBERON:0001621 | 83.94 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 83.88 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 83.81 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 83.71 | gold quality |
| vermiform appendix | UBERON:0001154 | 83.64 | gold quality |
| mucosa of stomach | UBERON:0001199 | 83.58 | gold quality |
| transverse colon | UBERON:0001157 | 83.55 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-125970 | yes | 71.77 |
| E-ANND-3 | yes | 5.02 |
| E-MTAB-6386 | no | 67.48 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
11 targeting FUOM, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-3605-5P | 99.96 | 67.12 | 932 |
| HSA-MIR-4719 | 99.73 | 72.10 | 3329 |
| HSA-MIR-6132 | 99.60 | 65.83 | 1554 |
| HSA-MIR-6836-5P | 99.60 | 65.62 | 1538 |
| HSA-MIR-6722-3P | 99.45 | 67.62 | 1919 |
| HSA-MIR-544B | 99.18 | 67.41 | 1632 |
| HSA-MIR-1909-3P | 99.03 | 66.56 | 1662 |
| HSA-MIR-3670 | 97.88 | 64.39 | 763 |
| HSA-MIR-873-3P | 96.84 | 66.09 | 786 |
| HSA-MIR-3918 | 96.13 | 64.65 | 1300 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | fuom | ENSDARG00000039422 |
| mus_musculus | Fuom | ENSMUSG00000025466 |
| rattus_norvegicus | Fuom | ENSRNOG00000018476 |
Protein
Protein identifiers
Fucose mutarotase — A2VDF0 (reviewed: A2VDF0)
All UniProt accessions (3): A2VDF0, X6R6T9, X6RK00
UniProt curated annotations — full annotation on UniProt →
Function. Involved in the interconversion between alpha- and beta-L-fucoses. L-Fucose (6-deoxy-L-galactose) exists as alpha-L-fucose (29.5%) and beta-L-fucose (70.5%), the beta-form is metabolized through the salvage pathway. GDP-L-fucose formed either by the de novo or salvage pathways is transported into the endoplasmic reticulum, where it serves as a substrate for N- and O-glycosylations by fucosyltransferases. Fucosylated structures expressed on cell surfaces or secreted in biological fluids are believed to play a critical role in cell-cell adhesion and recognition processes.
Subunit / interactions. Mainly homodimer, but also exists as homotetramer, homooctamer, and homodecamer. The homodimeric form seems catalytically inactive.
Pathway. Carbohydrate metabolism; L-fucose metabolism.
Similarity. Belongs to the RbsD / FucU family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| A2VDF0-1 | 1 | yes |
| A2VDF0-2 | 2 |
RefSeq proteins (4): NP_001091953, NP_001288756, NP_001288757, NP_940874 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007721 | RbsD_FucU | Family |
| IPR023750 | RbsD-like_sf | Homologous_superfamily |
| IPR050443 | RbsD/FucU_mutarotase | Family |
Pfam: PF05025
Enzyme classification (BRENDA):
- EC 5.1.3.29 — L-fucose mutarotase (BRENDA: 5 organisms, 7 substrates, 0 inhibitors, 0 Km, 0 kcat entries)
Catalyzed reactions (Rhea), 1 shown:
- alpha-L-fucose = beta-L-fucose (RHEA:25580)
UniProt features (12 total): binding site 5, active site 3, splice variant 2, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A2VDF0-F1 | 96.77 | 0.95 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (3): 24 (proton donor); 69; 120
Ligand- & substrate-binding residues (5): 32; 79; 120; 138; 140
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-6787639 | GDP-fucose biosynthesis |
MSigDB gene sets: 115 (showing top):
GOBP_NEGATIVE_REGULATION_OF_NEURON_DIFFERENTIATION, GOBP_BEHAVIOR, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN, GOBP_NEUROGENESIS, GOBP_ORGANOPHOSPHATE_METABOLIC_PROCESS, GOBP_NUCLEOSIDE_PHOSPHATE_BIOSYNTHETIC_PROCESS, GOBP_ORGANOPHOSPHATE_BIOSYNTHETIC_PROCESS, GOBP_CARBOHYDRATE_DERIVATIVE_METABOLIC_PROCESS, GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_METABOLIC_PROCESS, GOBP_REGULATION_OF_NEURON_DIFFERENTIATION, GOBP_CARBOHYDRATE_DERIVATIVE_BIOSYNTHETIC_PROCESS, GOBP_REPRODUCTIVE_BEHAVIOR, GOBP_CARBOHYDRATE_METABOLIC_PROCESS, GOBP_FUCOSE_METABOLIC_PROCESS
GO Biological Process (7): fucose metabolic process (GO:0006004), neuron differentiation (GO:0030182), GDP-L-fucose salvage (GO:0042352), negative regulation of neuron differentiation (GO:0045665), female mating behavior (GO:0060180), monosaccharide metabolic process (GO:0005996), obsolete fucosylation (GO:0036065)
GO Molecular Function (5): racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857), L-fucose mutarotase activity (GO:0036373), fucose binding (GO:0042806), isomerase activity (GO:0016853), monosaccharide binding (GO:0048029)
GO Cellular Component (1): cytosol (GO:0005829)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Synthesis of substrates in N-glycan biosythesis | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| hexose metabolic process | 1 |
| cell differentiation | 1 |
| generation of neurons | 1 |
| GDP-L-fucose biosynthetic process | 1 |
| metabolic compound salvage | 1 |
| neuron differentiation | 1 |
| negative regulation of cell differentiation | 1 |
| regulation of neuron differentiation | 1 |
| mating behavior | 1 |
| carbohydrate metabolic process | 1 |
| small molecule metabolic process | 1 |
| racemase and epimerase activity | 1 |
| racemase and epimerase activity, acting on carbohydrates and derivatives | 1 |
| monosaccharide binding | 1 |
| catalytic activity | 1 |
| carbohydrate binding | 1 |
| small molecule binding | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
194 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FUOM | DENND10 | Q8TCE6 | 643 |
| FUOM | GALM | Q96C23 | 519 |
| FUOM | ZNF511 | Q8NB15 | 507 |
| FUOM | FUCA1 | P04066 | 480 |
| FUOM | PRAP1 | Q96NZ9 | 480 |
| FUOM | ENOSF1 | Q7L5Y1 | 472 |
| FUOM | HTATIP2 | Q9BUP3 | 458 |
| FUOM | XYLB | O75191 | 453 |
| FUOM | SCART1 | Q4G0T1 | 420 |
| FUOM | CALY | Q9NYX4 | 392 |
| FUOM | KRTAP11-1 | Q8IUC1 | 384 |
| FUOM | SIAH1 | Q8IUQ4 | 377 |
| FUOM | SLC35H1 | Q9NQQ7 | 356 |
| FUOM | KRT17 | Q04695 | 334 |
| FUOM | TESPA1 | A2RU30 | 322 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FUOM | EEF1A2 | psi-mi:“MI:0914”(association) | 0.530 |
| TAFA3 | FUOM | psi-mi:“MI:0914”(association) | 0.350 |
| FUOM | PRRC2A | psi-mi:“MI:0914”(association) | 0.350 |
| UBA52 | FUOM | psi-mi:“MI:0914”(association) | 0.350 |
| NUDCD1 | FUOM | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (25): FUOM (Affinity Capture-MS), MLLT4 (Affinity Capture-MS), EEA1 (Affinity Capture-MS), PRRC1 (Affinity Capture-MS), TOMM34 (Affinity Capture-MS), FRA10AC1 (Affinity Capture-MS), EEF1A2 (Affinity Capture-MS), GPALPP1 (Affinity Capture-MS), GOLGA3 (Affinity Capture-MS), PKN1 (Affinity Capture-MS), RBM27 (Affinity Capture-MS), RNF123 (Affinity Capture-MS), DDX46 (Affinity Capture-MS), PRRC2A (Affinity Capture-MS), FUOM (Affinity Capture-MS)
ESM2 similar proteins: A1A8Z3, A1JRP2, A2VDF0, A4TNS5, A4W892, A5F769, A7FKQ0, A7MTL8, A7ZJC5, A8GB96, A9R3A9, B1JSU6, B2K8Q8, B2TUY1, B2VBT3, B4SZF9, B4TC11, B5BC59, B5F034, B5QX27, B5R6A2, B6I7Q4, B7LAF1, B7M6B3, B7MGK7, B7MPN4, C3LND6, C6DCF2, P24519, Q0P563, Q0T6Y0, Q0TJV1, Q1CAE9, Q1CFN2, Q1REI1, Q2NUL1, Q2SCM1, Q32IH8, Q4ZW81, Q57RK0
Diamond homologs: A1AEZ1, A2VDF0, A3N2Y4, A5UAS6, A5UHL6, A6TD85, A7ZQP8, A8A3T9, A8AP17, A9MSA4, A9N2J4, B0BSB3, B0US22, B1IU37, B1LQZ8, B1VU78, B1XDL3, B2TZD0, B3H2T2, B4T4X3, B4TGN5, B4TUJ9, B5BF33, B5F4S5, B5FTY3, B5QWR2, B5RDV6, B5XUY2, B5Z4C4, B6I6K2, B7LEY4, B7LXM0, B7MLC5, B7MZA0, B7N738, B7NVV2, B7UHM0, B8F6Y2, C0PXG7, C3JZP4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
33 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 29 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
956 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:133355810:CT:C | acceptor_gain | 1.0000 |
| 10:133356934:AG:A | donor_gain | 1.0000 |
| 10:133356934:AGC:A | donor_gain | 1.0000 |
| 10:133356935:G:C | donor_gain | 1.0000 |
| 10:133356942:CCGGA:C | donor_gain | 1.0000 |
| 10:133356950:T:A | donor_gain | 1.0000 |
| 10:133357009:CAGGC:C | acceptor_gain | 1.0000 |
| 10:133357010:AGGC:A | acceptor_gain | 1.0000 |
| 10:133357011:GGC:G | acceptor_gain | 1.0000 |
| 10:133357012:GC:G | acceptor_gain | 1.0000 |
| 10:133357012:GCC:G | acceptor_loss | 1.0000 |
| 10:133357013:CC:C | acceptor_gain | 1.0000 |
| 10:133357013:CCTGG:C | acceptor_loss | 1.0000 |
| 10:133357014:C:A | acceptor_loss | 1.0000 |
| 10:133357014:C:CC | acceptor_gain | 1.0000 |
| 10:133357015:T:C | acceptor_loss | 1.0000 |
| 10:133357918:CTCA:C | donor_loss | 1.0000 |
| 10:133357920:CAC:C | donor_loss | 1.0000 |
| 10:133357921:A:AC | donor_gain | 1.0000 |
| 10:133357922:C:CC | donor_gain | 1.0000 |
| 10:133357922:C:CT | donor_loss | 1.0000 |
| 10:133357922:CCGAT:C | donor_gain | 1.0000 |
| 10:133355808:CTCT:C | acceptor_gain | 0.9900 |
| 10:133355812:C:CC | acceptor_gain | 0.9900 |
| 10:133356634:GCTTA:G | donor_loss | 0.9900 |
| 10:133356635:CTTA:C | donor_loss | 0.9900 |
| 10:133356636:TTACC:T | donor_loss | 0.9900 |
| 10:133356638:ACC:A | donor_loss | 0.9900 |
| 10:133356735:CAGC:C | acceptor_gain | 0.9900 |
| 10:133356738:CCTAG:C | acceptor_loss | 0.9900 |
AlphaMissense
975 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:133355779:A:C | F119L | 0.986 |
| 10:133355779:A:T | F119L | 0.986 |
| 10:133355781:A:G | F119L | 0.986 |
| 10:133357236:G:C | F35L | 0.982 |
| 10:133357236:G:T | F35L | 0.982 |
| 10:133357238:A:G | F35L | 0.982 |
| 10:133355755:A:C | F127L | 0.978 |
| 10:133355755:A:T | F127L | 0.978 |
| 10:133355757:A:G | F127L | 0.978 |
| 10:133355753:G:T | A128D | 0.977 |
| 10:133357255:A:T | V29D | 0.976 |
| 10:133355769:C:G | A123P | 0.973 |
| 10:133355400:C:A | K145N | 0.970 |
| 10:133355400:C:G | K145N | 0.970 |
| 10:133355399:C:A | G146W | 0.969 |
| 10:133355407:A:T | L143H | 0.969 |
| 10:133355747:A:T | V130E | 0.969 |
| 10:133355399:C:G | G146R | 0.968 |
| 10:133355399:C:T | G146R | 0.968 |
| 10:133355419:C:T | G139E | 0.968 |
| 10:133355750:A:T | V129D | 0.968 |
| 10:133355768:G:T | A123D | 0.966 |
| 10:133355780:A:G | F119S | 0.966 |
| 10:133357245:G:C | D32E | 0.966 |
| 10:133357245:G:T | D32E | 0.966 |
| 10:133357246:T:A | D32V | 0.963 |
| 10:133357925:A:T | I28N | 0.963 |
| 10:133355413:A:G | L141P | 0.961 |
| 10:133355413:A:T | L141H | 0.960 |
| 10:133355415:G:C | N140K | 0.960 |
dbSNP variants (sampled 300 via entrez): RS1000589020 (10:133355566 C>T), RS1000958148 (10:133355309 G>A), RS1001017078 (10:133356910 A>C), RS1001713961 (10:133355037 C>T), RS1001746720 (10:133355235 C>A,G), RS1002517729 (10:133354201 T>G), RS1002592780 (10:133358034 C>A,G,T), RS1002789113 (10:133359811 G>A,T), RS1002970376 (10:133357754 A>G,T), RS1003392717 (10:133353721 G>A,T), RS1003423763 (10:133354101 G>A), RS1003794446 (10:133358518 G>A,T), RS1004068518 (10:133359189 C>T), RS1004502492 (10:133353218 G>C), RS1004533499 (10:133353434 C>T)
Disease associations
OMIM: gene MIM:617725 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007250_1 | Nonunion in individuals with fractures | 2.000000e-08 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009707 | fractures, ununited |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
34 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases expression | 3 |
| Benzo(a)pyrene | decreases expression, increases methylation | 3 |
| Arsenic | affects methylation, increases methylation | 2 |
| Aflatoxin B1 | affects expression, decreases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| methyleugenol | decreases expression | 1 |
| propionaldehyde | increases expression | 1 |
| bisphenol A | increases methylation | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| beta-lapachone | decreases expression, increases expression | 1 |
| butyraldehyde | increases expression | 1 |
| pentanal | increases expression | 1 |
| jinfukang | increases expression | 1 |
| Rosiglitazone | decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Aldehydes | increases expression | 1 |
| Diazinon | increases methylation | 1 |
| Lead | affects methylation | 1 |
| N-Nitrosopyrrolidine | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Vanadates | increases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.